178 related articles for article (PubMed ID: 2034308)
1. [Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
Rüttinger H; Rüttinger P; Hermes M
Nervenarzt; 1991 Feb; 62(2):127-9. PubMed ID: 2034308
[No Abstract] [Full Text] [Related]
2. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
Rüttinger H; Hermes M
Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
[No Abstract] [Full Text] [Related]
3. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
[TBL] [Abstract][Full Text] [Related]
4. [Progress of research in the diagnosis of multiple sclerosis by study of the cerebrospinal fluid].
Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
Psychiatr Neurol Med Psychol (Leipz); 1987 Nov; 39(11):651-61. PubMed ID: 2450384
[TBL] [Abstract][Full Text] [Related]
5. CSF studies in EAE and MS.
Tourtellotte WW
Prog Clin Biol Res; 1984; 146():329-33. PubMed ID: 6718425
[No Abstract] [Full Text] [Related]
6. [The immune status as an indicator for parameter-dependent therapy of multiple sclerosis?].
Kuppe G; Schmidt RM; Ludewig R
Nervenarzt; 1989 Sep; 60(9):549-52. PubMed ID: 2812159
[No Abstract] [Full Text] [Related]
7. [Magnetic resonance imaging of disseminated sclerosis].
Christiansen AP; Wanscher B; Larsson HB; Henriksen O
Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
[TBL] [Abstract][Full Text] [Related]
8. [Subclasses of IgG in the cerebrospinal fluid oligoclonal bands of multiple sclerosis patients. Preliminary studies].
Grimaldi LM; Maimone D; De Simone D; Finocchiaro AM; Reggio A
Acta Neurol (Napoli); 1986 Jun; 8(3):221-5. PubMed ID: 3739768
[No Abstract] [Full Text] [Related]
9. Hypothesis: multiple sclerosis cerebrospinal fluid IgG multiple bands are derived from one or a few IgG secretor cell clones.
Tourtellotte WW; Shapshak P; Staugaitis SM; Saxton RE
Prog Clin Biol Res; 1984; 146():371-8. PubMed ID: 6718429
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
Gowin W; Weihe W; Appel C; Mariss G
Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
[No Abstract] [Full Text] [Related]
11. The separation and detection of alkaline oligoclonal IgG bands in cerebrospinal fluid using immobilised pH gradients.
Cowdrey G; Gould B; Rees J; Firth G
Electrophoresis; 1990 Oct; 11(10):813-8. PubMed ID: 2079020
[TBL] [Abstract][Full Text] [Related]
12. The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings.
Trojano M; Logroscino GC; Pisicchio L; Rosato A; Bordo B; Citterio A; Amato MP; Livrea P
Ital J Neurol Sci; 1987 Jun; Suppl 6():71-6. PubMed ID: 3654180
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
Staffen W; Trinka E; Ladurner G
Nervenarzt; 1993 Apr; 64(4):226-32. PubMed ID: 8506010
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis.
Thompson EJ; Freedman MS
Adv Neurol; 2006; 98():147-60. PubMed ID: 16400832
[No Abstract] [Full Text] [Related]
15. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of contrast media in magnetic resonance imaging.
Bydder GM
Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
[TBL] [Abstract][Full Text] [Related]
17. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
[TBL] [Abstract][Full Text] [Related]
19. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
[No Abstract] [Full Text] [Related]
20. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
Calabresi PA; Tranquill LR; Dambrosia JM; Stone LA; Maloni H; Bash CN; Frank JA; McFarland HF
Ann Neurol; 1997 May; 41(5):669-74. PubMed ID: 9153530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
